Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans.
about
The Physiological Regulation of Skeletal Muscle Fatty Acid Supply and Oxidation During Moderate-Intensity ExerciseNatriuretic Peptides and Cardiometabolic HealthAtrial natriuretic peptide in cardiovascular biology and disease (NPPA)Aerobic exercise training improves atrial natriuretic peptide and catecholamine-mediated lipolysis in obese women with polycystic ovary syndrome.Insulin-mimetic compound hexaquis (benzylammonium) decavanadate is antilipolytic in human fat cells.Neural innervation of white adipose tissue and the control of lipolysis.Adaptive thermogenesis in adipocytes: is beige the new brown?Cardiac natriuretic peptides in plasma increase after dietary induced weight loss in obesity.Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytesHeart Failure With Preserved Ejection Fraction Induces Beiging in Adipose Tissue.Involvement of the atrial natriuretic peptide in cardiovascular pathophysiology and its relationship with exerciseBeta-adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulationPhosphodiesterase-5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide-mediated lipolysis.Natriuretic peptides enhance the oxidative capacity of human skeletal muscle.Atrial natriuretic peptide induces postprandial lipid oxidation in humansAssociation of β-2 adrenergic agonist and corticosteroid injection in the treatment of lipomas.Influence of regular physical activity and caloric restriction on β-adrenergic and natriuretic peptide receptor expression in retroperitoneal adipose tissue of OLETF rats.Does continuous endurance exercise in water elicit a higher release of ANP and BNP and a higher plasma concentration of FFAs in pre-obese and obese men than high intensity intermittent endurance exercise? - study protocol for a randomized controlledEpac2a-null mice exhibit obesity-prone nature more susceptible to leptin resistance.All-trans retinoic acid stimulates gene expression of the cardioprotective natriuretic peptide system and prevents fibrosis and apoptosis in cardiomyocytes of obese ob/ob mice.Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity.Natriuretic peptides: new players in energy homeostasis.Acute exposure to long-chain fatty acids impairs {alpha}2-adrenergic receptor-mediated antilipolysis in human adipose tissue.Adrenaline but not noradrenaline is a determinant of exercise-induced lipid mobilization in human subcutaneous adipose tissue.Effect of exercise training on cardiac oxytocin and natriuretic peptide systems in ovariectomized rats.Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue.Metabolic effects of sacubitril/valsartan: are they relevant in clinical practice?
P2860
Q26778295-DDF0C5EB-8FD8-459D-BD7C-49BE669409E8Q26827702-04AE375E-EDD1-4D86-8A80-7EAF8BAD0F48Q28082833-32F67244-89C3-4CB9-B5DA-A6F1B4554B36Q33569817-E7F2B398-C265-40BD-A647-8354B2E190B9Q33573165-730AB950-11DF-4ABD-9123-1420B10F548AQ34244188-F7EF4D99-B2F1-4401-8F8C-46666446BEBCQ34326605-D1DBEF2D-B2E8-4B0A-B33D-B29EE379C38EQ35718443-84D04E4F-2D37-4804-89D2-8F1F57ED17FEQ35780260-82013037-0D77-450A-A089-845B033C2AFAQ35882942-B2C93923-B232-41B9-A61B-C33820E8DC33Q36092429-275A6193-821E-42AA-8E0A-A47983FB450CQ36131187-9918CC38-FCD6-4EF0-9F54-41A51F60CF0AQ36171364-E87DE950-7929-432D-BBDE-143A12EB8DCDQ36498070-7B31FB1A-5F3E-4D9F-826B-9E6C0E66670EQ36975436-28CAD8F8-F4B4-4F9E-BD0E-6C518DB7975FQ37166419-D8D55A28-D9AF-4BC1-8D22-65A159588266Q37339172-3D5145C2-8526-44EA-A248-FF8BFB0DBAEBQ37365813-869C7B4B-C374-460D-BC9C-71FF579535CAQ37642259-608110CD-5B5D-4375-9A4A-AFEB8FA92E5AQ38305811-FC1380F6-62AE-4B83-82FB-3B0E5215AEBEQ41886648-1FA7CA5A-6303-49F7-8558-8227A867ECBAQ42019825-7413E3E9-3C8B-4005-A41F-571FCD5F68B3Q42515724-D909FBA1-C6EB-49C2-B989-9C92FF276992Q46024747-E9B04372-537C-408C-ACF2-E2C29698CC0BQ48180907-1B083E46-C09A-44AC-A595-29B0373EC5F6Q52338665-36C8331F-B79E-4C95-91AD-A38F5D81E1CAQ58804503-01281C38-E19A-453D-8B7C-8E6FF8274645
P2860
Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Atrial natriuretic peptide con ...... lipid mobilization in humans.
@en
Atrial natriuretic peptide con ...... lipid mobilization in humans.
@nl
type
label
Atrial natriuretic peptide con ...... lipid mobilization in humans.
@en
Atrial natriuretic peptide con ...... lipid mobilization in humans.
@nl
prefLabel
Atrial natriuretic peptide con ...... lipid mobilization in humans.
@en
Atrial natriuretic peptide con ...... lipid mobilization in humans.
@nl
P2093
P50
P356
P1433
P1476
Atrial natriuretic peptide con ...... f lipid mobilization in humans
@en
P2093
Claire Thalamas
Francois Crampes
Jean Galitzky
Max Lafontan
Michel Berlan
P304
P356
10.1096/FJ.03-1086FJE
P407
P577
2004-03-19T00:00:00Z